Life Science News

11 July 2003 - Merck to shut down Lyon site - 320 pharma jobs to go in France

Merck KGaA restructuring pharma activities in Lacassagne France will close R&D and production by 2006 Merck KGaA based in Darmstadt, Germany has decided..  More >>

10 July 2003 - SYN•X to raise $5m to fund CHF diagnostic launch

Debenture financing plus share option warrants issued Toronto’s proteomics company with a focus on point-of-care diagnostics has issued $3 million in..  More >>

10 July 2003 - Elan divests its patch business to Nitto Denko

Nitto Denko acquires Elan Transdermal Technolgies, Inc. Move paves way for Nitto’s drug delivery technologies expansion worldwide. As part of a continuing..  More >>

10 July 2003 - Hungary for contract business - Canada's LAB bites $2m CRO

LAB International acquires Hungarian Toxicological Research Centre LAB ’expanding core CRO services in European arena’ LAB International based in Laval, QC..  More >>

07 July 2003 - Grant aid for $41m UK manufacturing development at Ivax

Ivax Pharmaceuticals completes site with help from $6 million grant Ivax Pharmaceuticals, the UK subsidiary of Miami’s Ivax Corporation, currently..  More >>

04 July 2003 - Europe steps up disease prevention effort with €9 million for SARS research

Commission investing €9 million to fund research into SARS prevention: first tranche of €1.11bn ’to combat major diseases’ Initiative should ’pave way..  More >>

03 July 2003 - Orion to shut down pharma manufacturing in Denmark

Orion Pharma centralises its manufacturing in Finland, shedding 65 jobs The pharmaceutical unit of Orion Corporation is to close its manufacturing operations..  More >>

03 July 2003 - Vernalis agrees £91m merger plan with British Biotech

British Biotech to acquire Vernalis for £48m Biopharma group Vernalis plc based near Reading, UK has agreed to a £48 million (€69.7m; $80m) acquisition by its..  More >>

02 July 2003 - Successful results for DDS microspheres in brain cancer

Ethypharm’s 5-FU loaded microspheres "positively better in first line glioblastoma cancer therapy."  Partnering opportunities for..  More >>

02 July 2003 - Double whammy for Welsh pharma

Penn wins Queen’s Award and far exceeds target revenues Photo: Penn CEO, Craig Rennie with Queen’s Award 2003 Leading player among integrated pharmaceutical..  More >>

02 July 2003 - FOR SALE - Pharmacia Diagnostics business

Pfizer explores the strategic options for Pharmacia Diagnostics business Pfizer Inc. is considering selling its Pharmacia Diagnostics business among its..  More >>

01 July 2003 - New combination for Type 2 diabetes gets CPMP backing

Positive opinion for GlaxoSmithKline’s Avandamet™ from EMEA’s CPMP for EU Combination therapy "key to effective type 2 diabetes management" Avandamet™, the..  More >>